203 related articles for article (PubMed ID: 32994248)
1. Longitudinal exploration of cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma: protocol for a feasibility study.
Gates P; Gough K; Dhillon H; Wilson C; Hawkes E; Dore V; Perchyonok Y; Rowe CC; Walker AK; Vardy JL; de Ruiter M; Krishnasamy M
BMJ Open; 2020 Sep; 10(9):e038312. PubMed ID: 32994248
[TBL] [Abstract][Full Text] [Related]
2. Cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma undergoing standard chemotherapy: a longitudinal feasibility study.
Gates P; Krishnasamy M; Wilson C; Hawkes EA; Doré V; Perchyonok Y; Rowe CC; Walker AK; Vardy JL; de Ruiter MB; Cushion T; Dhillon HM; Gough K
Support Care Cancer; 2022 Sep; 30(9):7731-7743. PubMed ID: 35699780
[TBL] [Abstract][Full Text] [Related]
3. Web-based cognitive rehabilitation intervention for cancer-related cognitive impairment following chemotherapy for aggressive lymphoma: protocol for a randomised pilot trial.
Gates P; Green HJ; Gough K; Dhillon H; Vardy JL; Dickinson M; Guarnera J; Krishnasamy M; Livingston PM; White V; Ugalde A; Caeyenberghs K
BMJ Open; 2024 Apr; 14(4):e081084. PubMed ID: 38653511
[TBL] [Abstract][Full Text] [Related]
4. Protocol for Care After Lymphoma (CALy) trial: a phase II pilot randomised controlled trial of a lymphoma nurse-led model of survivorship care.
Taylor K; Joske D; Bulsara M; Bulsara C; Monterosso L
BMJ Open; 2016 May; 6(5):e010817. PubMed ID: 27194317
[TBL] [Abstract][Full Text] [Related]
5. Impact of hearing loss and vestibular decline on cognition in Alzheimer's disease: a prospective longitudinal study protocol (Gehoor, Evenwicht en Cognitie, GECkO).
Bosmans J; Jorissen C; Cras P; Van Ombergen A; Engelborghs S; Gilles A; Princen E; Moyaert J; Mertens G; Van Rompaey V
BMJ Open; 2020 Sep; 10(9):e039601. PubMed ID: 32948575
[TBL] [Abstract][Full Text] [Related]
6. Exploration of motivation to participate in a study of cancer-related cognitive impairment among patients with newly diagnosed aggressive lymphoma: a qualitative sub-study.
Gates P; Dhillon H; Gough K; Wilson C; Hawkes E; Scudder L; Cushion T; Krishnasamy M
Support Care Cancer; 2022 Feb; 30(2):1331-1339. PubMed ID: 34495384
[TBL] [Abstract][Full Text] [Related]
7. Cancer-related cognitive impairment and wellbeing in patients with newly diagnosed aggressive lymphoma compared to population norms and healthy controls: an exploratory study.
Gates P; Dhillon HM; Krishnasamy M; Wilson C; Gough K
Support Care Cancer; 2024 Mar; 32(4):238. PubMed ID: 38512692
[TBL] [Abstract][Full Text] [Related]
8. Electroacupuncture for Cancer-Related Cognitive Impairment: A Clinical Feasibility Study.
Lyu YR; Lee HY; Park HJ; Kwon OJ; Kim AR; Jung IC; Park YC; Cho JH; Kim JE; Kim M; Lee JH; Kim JH
Integr Cancer Ther; 2022; 21():15347354221098983. PubMed ID: 35608027
[TBL] [Abstract][Full Text] [Related]
9. Enhancing community participation for stroke survivors with cognitive impairment: study protocol for a randomised controlled trial in Taiwan.
Chang FH; Chiu V; Ni P; Lin YN; Kang JH; Liou TH; Lu L; Han DS; Skidmore ER
BMJ Open; 2020 Dec; 10(12):e040241. PubMed ID: 33293312
[TBL] [Abstract][Full Text] [Related]
10. Neuromodulation through brain stimulation-assisted cognitive training in patients with post-COVID-19 cognitive impairment (Neuromod-COV): study protocol for a PROBE phase IIb trial.
Thams F; Antonenko D; Fleischmann R; Meinzer M; Grittner U; Schmidt S; Brakemeier EL; Steinmetz A; Flöel A
BMJ Open; 2022 Apr; 12(4):e055038. PubMed ID: 35410927
[TBL] [Abstract][Full Text] [Related]
11. UNITE Project: understanding neurocognitive impairment after trauma exposure-study protocol of an observational study in Christchurch, New Zealand.
Douglas K; Bell C; Tanveer S; Eggleston K; Porter R; Boden J
BMJ Open; 2023 Aug; 13(8):e072195. PubMed ID: 37550025
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of eight-style Tai chi on cognitive function in patients with cognitive impairment of cerebral small vessel disease: study protocol for a randomised controlled trial.
Zhong X; Yan X; Liang H; Xia R; Chen B; Zhao HJ
BMJ Open; 2021 Feb; 11(2):e042177. PubMed ID: 33558352
[TBL] [Abstract][Full Text] [Related]
13. Cognitive impairment and psychopathology in out-of-hospital cardiac arrest survivors in Denmark: The REVIVAL cohort study protocol.
Wagner MK; Berg SK; Hassager C; Armand S; Møller JE; Ekholm O; Rasmussen TB; Fisher PM; Knudsen GM; Stenbæk DS
BMJ Open; 2020 Sep; 10(9):e038633. PubMed ID: 32994252
[TBL] [Abstract][Full Text] [Related]
14. Guided internet-administered self-help to reduce symptoms of anxiety and depression among adolescents and young adults diagnosed with cancer during adolescence (U-CARE: YoungCan): a study protocol for a feasibility trial.
Ander M; Wikman A; Ljótsson B; Grönqvist H; Ljungman G; Woodford J; Lindahl Norberg A; von Essen L
BMJ Open; 2017 Jan; 7(1):e013906. PubMed ID: 28132011
[TBL] [Abstract][Full Text] [Related]
15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
16. Neuroinflammation in cognitive decline post-cardiac surgery (the FOCUS study): an observational study protocol.
Peters van Ton AM; Duindam HB; van Tuijl J; Li WW; Dieker HJ; Riksen NP; Meijer FA; Kessels RP; Kohn N; van der Hoeven JG; Pickkers P; Rijpkema M; Abdo WF
BMJ Open; 2021 May; 11(5):e044062. PubMed ID: 33980522
[TBL] [Abstract][Full Text] [Related]
17. Effects of Supervised Early Resistance Training versus standard care on cognitive recovery following cardiac surgery via median sternotomy (the SEcReT study): protocol for a randomised controlled pilot study.
Pengelly JMS; Royse AG; Bryant AL; Williams GP; Tivendale LJ; Dettmann TJ; Canty DJ; Royse CF; El-Ansary DA
Trials; 2020 Jul; 21(1):649. PubMed ID: 32669111
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Cognition Support Formula® on cognitive function in older adults with subjective cognitive impairment: a protocol for a 26-week, randomised, double-blind, placebo-controlled trial.
Cave AE; Chang DH; Münch GW; Steiner GZ
Trials; 2019 Jun; 20(1):345. PubMed ID: 31182153
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment Cancer-Related Cognitive Impairment in Hodgkin Lymphoma Patients.
Juríčková V; Fayette D; Jonáš J; Fajnerová I; Kozák T; Horáček J
Curr Oncol; 2023 Oct; 30(10):9028-9038. PubMed ID: 37887552
[TBL] [Abstract][Full Text] [Related]
20. Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: protocol for a scoping review.
Mayo SJ; Kuruvilla J; Laister RC; Ayala AP; Alm M; Byker W; Kelly DL; Saligan L
BMJ Open; 2018 Jan; 8(1):e017578. PubMed ID: 29374660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
